Also trades as: TMED.CN (CNQ) · $vol 0M
EVAHF OTC
EGF Theramed Health Corp.
1W: +0.0%
1M: +0.0%
3M: -26.7%
YTD: -43.6%
1Y: -65.1%
3Y: -90.0%
5Y: -64.5%
$0.02
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+100.0% ▲
Operating Income
$0
+100.0% ▲
Net Income
-$3M
-1014.2% ▼
EPS (Diluted)
$0.00
+100.0% ▲
EBITDA
-$2M
+0.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $105K | $0 | $0 | $3K | $0 |
| Gross Profit | -$105K | $0 | $0 | -$3K | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $233K | $0 | $0 | $0 | $0 |
| SG&A Expenses | $761K | $971K | $434K | $228K | $275K |
| Operating Expenses | $1M | $1M | $606K | $294K | $275K |
| Operating Income | -$1M | -$1M | -$606K | -$297K | $0 |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $65K | $15K | $38K | $36K | $66K |
| Income Before Tax | -$744K | -$1M | -$643K | -$296K | -$2M |
| Tax Expense | $0 | $0 | $0 | $0 | $833K |
| Net Income | -$974K | -$1M | -$623K | -$269K | -$3M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.91 | $-0.63 | $-0.06 | $-0.02 | $0.00 |
| EBITDA | -$1M | -$990K | -$567K | $0 | -$2M |
| Shares Outstanding | 1M | 2M | 10M | 11M | 12M |